3RP Trademark

Trademark Overview

On Thursday, April 5, 2001, a trademark application was filed for 3RP with the United States Patent and Trademark Office. The USPTO has given the 3RP trademark a serial number of 76236223. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, October 31, 2014. This trademark is owned by Three Rivers Pharmaceuticals, LLC. The 3RP trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

PHARMACEUTICAL DRUG DEVELOPMENT SERVICES, NAMELY, DEVELOPMENT OF GENERIC PRESCRIPTION DRUGS
3rp

General Information

Serial Number76236223
Word Mark3RP
Filing DateThursday, April 5, 2001
Status710 - CANCELLED - SECTION 8
Status DateFriday, October 31, 2014
Registration Number2828263
Registration DateTuesday, March 30, 2004
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 2, 2002

Trademark Statements

Goods and ServicesPHARMACEUTICAL DRUG DEVELOPMENT SERVICES, NAMELY, DEVELOPMENT OF GENERIC PRESCRIPTION DRUGS

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, October 31, 2014
Primary Code042
First Use Anywhere DateTuesday, April 8, 2003
First Use In Commerce DateTuesday, April 8, 2003

Trademark Owner History

Party NameKADMON PHARMACEUTICALS, LLC
Party Type32 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressWARRENDALE, PA 15086
Party NameKADMON PHARMACEUTICALS, LLC
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressWARRENDALE, PA 15086
Party NameThree Rivers Pharmaceuticals, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressWarrendale, PA 15086
Party NameThree Rivers Pharmaceuticals, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressPittsburgh, PA 15214
Party NameThree Rivers Pharmaceuticals, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressPittsburgh, PA 15214

Trademark Events

Event DateEvent Description
Friday, October 31, 2014CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Monday, January 21, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, August 31, 2011AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, August 10, 2011AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, January 13, 2011APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, January 13, 2011TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, January 13, 2011ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, January 13, 2011TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, December 22, 2009REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, December 21, 2009CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, December 11, 2009TEAS SECTION 8 & 15 RECEIVED
Tuesday, March 30, 2004REGISTERED-PRINCIPAL REGISTER
Wednesday, January 21, 2004ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, January 15, 2004ASSIGNED TO EXAMINER
Wednesday, January 14, 2004CASE FILE IN TICRS
Thursday, January 8, 2004STATEMENT OF USE PROCESSING COMPLETE
Thursday, April 17, 2003USE AMENDMENT FILED
Friday, March 28, 2003EXTENSION 1 GRANTED
Monday, March 24, 2003EXTENSION 1 FILED
Friday, October 31, 2003PETITION TO REVIVE-GRANTED
Thursday, April 17, 2003PETITION TO REVIVE-RECEIVED
Tuesday, August 19, 2003ABANDONMENT - NO USE STATEMENT FILED
Thursday, April 17, 2003PAPER RECEIVED
Tuesday, September 24, 2002NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 2, 2002PUBLISHED FOR OPPOSITION
Wednesday, June 12, 2002NOTICE OF PUBLICATION
Friday, March 15, 2002APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 7, 2001CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 8, 2001NON-FINAL ACTION MAILED
Thursday, May 31, 2001ASSIGNED TO EXAMINER
Wednesday, May 23, 2001ASSIGNED TO EXAMINER

Related Keywords

development prescription drugs generic services drug pharmaceutical namely